Showing papers on "European union published in 2022"

European Green Deal

Abstract: This article aims to present the main objectives and characteristics of the European Green Deal, which is a kind of roadmap for achieving the sustainability of the EU economy by turning climate and environmental challenges into opportunities in all policy areas, through a just and inclusive transition for all. The implementation of this roadmap provides for actions to use resources efficiently by moving to a circular economy, reducing biodiversity loss and diminishing pollution. The roadmap also sets out the necessary investments and financial instruments and the need to ensure a just and inclusive transition. Transforming the economy of the European Union (EU) into a resource-efficient economy in which economic growth is not directly linked to the use of resources, based on the cessation of net emissions by 2050. The European Green Deal outlines a plan for this transformative change.

Challenges toward carbon neutrality in China: Strategies and countermeasures

Abstract: In response to climate change, the Chinese government has set a clear goal to reach its carbon peak by 2030 and achieve carbon neutrality by 2060, endeavoring to gradually realize net-zero carbon dioxide (CO2) emissions. This paper explores the concept of carbon neutrality and makes a comparative analysis of the gap between China, the European Union, and the United States vis-a-vis carbon neutrality based on international data. The main challenges China faces in its progress toward carbon neutrality are the following: first, China's energy consumption and CO2 emissions continue to increase, while its carbon peak has not yet been reached; second, carbon emission reduction in China is an arduous process, as the transition period allowed for the country to transition from its carbon peak to carbon neutrality is shorter than that of developed countries; third, China remains reliant on high-carbon fossil energy, with high energy consumption and low energy utilization efficiency; fourth, China's low level of economic development, compared with those of the EU, the US, or other developed countries, makes it relatively weak to withstand economic risks; and fifth, China's low-carbon and zero-carbon technologies are not mature. Therefore, this paper posits a three-stage/four-step strategy as well as seven specific suggestions that could benefit China's progress toward carbon neutrality.

Antibodies to watch in 2022

Abstract: ABSTRACT In this 13th annual installment of the annual ‘Antibodies to Watch’ article series, we discuss key events in commercial antibody therapeutics development that occurred in 2021 and forecast events that might occur in 2022. Regulatory review of antibody therapeutics that target the SARS-CoV-2 coronavirus proceeded at an unprecedented pace in 2021, resulting in both emergency use authorizations and full approvals for sotrovimab, regdanvimab, REGEN-COV2, as well as others, in numerous countries. As of November 1, a total of 11 antibody therapeutics had been granted first approvals in either the United States or European Union in 2021 (evinacumab, dostarlimab loncastuximab tesirine, amivantamab, aducanumab, tralokinumab, anifrolumab, bimekizumab, tisotumab vedotin, regdanvimab, REGEN-COV2). The first global approvals of seven products, however, were granted elsewhere, including Japan (pabinafusp alfa), China (disitamab vedotin, penpulimab, zimberelimab), Australia (sotrovimab, REGEN-COV2), or the Republic of Korea (regdanvimab). Globally, at least 27 novel antibody therapeutics are undergoing review by regulatory agencies. First actions by the Food and Drug Administration on the biologics license applications for faricimab, sutimlimab, tebentafusp, relatlimab, sintilimab, ublituximab and tezepelumab are expected in the first quarter of 2022. Finally, our data show that, with antibodies for COVID-19 excluded, the late-stage commercial clinical pipeline of antibody therapeutics grew by over 30% in the past year. Of those in late-stage development, marketing applications for at least 22 may occur by the end of 2022.

The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2019–2020

Abstract: Abstract Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs), jointly analysed by the EFSA and the ECDC and reported in a yearly EU Summary Report. The annual monitoring of AMR in animals and food within the EU is targeted at selected animal species corresponding to the reporting year. The 2020 monitoring specifically focussed on poultry and their derived carcases/meat, while the monitoring performed in 2019 specifically focused on fattening pigs and calves under 1 year of age, as well as their derived carcases/meat. Monitoring and reporting of AMR in 2019–2020 included data regarding Salmonella, Campylobacter and indicator E. coli isolates, as well as data obtained from the specific monitoring of presumptive ESBL‐/AmpC‐/carbapenemase‐producing E. coli isolates. Additionally, some MSs reported voluntary data on the occurrence of methicillin‐resistant Staphylococcus aureus in animals and food, with some countries also providing data on antimicrobial susceptibility. This report provides an overview of the main findings of the 2019–2020 harmonised AMR monitoring in the main food‐producing animal populations monitored, in carcase/meat samples and in humans. Where available, monitoring data obtained from pigs, calves, broilers, laying hens and turkeys, as well as from carcase/meat samples and humans were combined and compared at the EU level, with particular emphasis on multidrug resistance, complete susceptibility and combined resistance patterns to critically important antimicrobials, as well as Salmonella and E. coli isolates possessing ESBL‐/AmpC‐/carbapenemase phenotypes. The key outcome indicators for AMR in food‐producing animals, such as complete susceptibility to the harmonised panel of antimicrobials in E. coli and the prevalence of ESBL‐/AmpC‐producing E. coli have been specifically analysed over the period 2014–2020.

The European Union One Health 2021 Zoonoses Report

Abstract: Abstract This report of the European Food Safety Authority and the European Centre for Disease Prevention and Control presents the results of zoonoses monitoring and surveillance activities carried out in 2021 in 27 MSs, the United Kingdom (Northern Ireland) and nine non‐MSs. Key statistics on zoonoses and zoonotic agents in humans, food, animals and feed are provided and interpreted historically. In 2021, the first and second most reported zoonoses in humans were campylobacteriosis and salmonellosis, respectively. Cases of campylobacteriosis and salmonellosis increased in comparison with 2020, but decreased compared with previous years. In 2021, data collection and analysis at the EU level were still impacted by the COVID‐19 pandemic and the control measures adopted in the MSs, including partial or total lockdowns. Sixteen MSs and the United Kingdom (Northern Ireland) achieved all the established targets in poultry populations for reduction in Salmonella prevalence for the relevant serovars. Salmonella samples from carcases of various animal species and samples for Campylobacter quantification from broiler carcases were more frequently positive when performed by the competent authorities than when own‐checks were conducted. Yersiniosis was the third most reported zoonosis in humans, followed by Shiga toxin‐producing Escherichia coli (STEC) and Listeria monocytogenes infections. L. monocytogenes and West Nile virus infections were the most severe zoonotic diseases, with the most hospitalisations and highest case fatality rates. Overall, MSs reported more foodborne outbreaks and cases in 2021 than in 2020. S. Enteritidis remained the most frequently reported causative agent for foodborne outbreaks. Salmonella in ‘eggs and egg products’ and in ‘mixed foods’ were the agent/food pairs of most concern. Outbreaks linked to ‘vegetables and juices and products thereof’ rose considerably compared with previous years. This report also provides updates on brucellosis, Coxiella burnetii (Q fever), echinococcosis, rabies, toxoplasmosis, trichinellosis, tuberculosis due to Mycobacterium bovis or M. caprae, and tularaemia.

Epidemiological analyses of African swine fever in the European Union

Abstract: Abstract This report provides a descriptive analysis of the African swine fever (ASF) Genotype II epidemic in the affected Member States in the EU and two neighbouring countries for the period from 1 September 2020 to 31 August 2021. ASF continued to spread in wild boar in the EU, it entered Germany in September 2020, while Belgium became free from ASF in October 2020. No ASF outbreaks in domestic pigs nor cases in wild boar have been reported in Greece since February 2020. In the Baltic States, overall, there has been a declining trend in proportions of polymerase chain reaction (PCR)‐positive samples from wild boar carcasses in the last few years. In the other countries, the proportions of PCR‐positive wild boar carcasses remained high, indicating continuing spread of the disease. A systematic literature review revealed that the risk factors most frequently significantly associated with ASF in domestic pigs were pig density, low levels of biosecurity and socio‐economic factors. For wild boar, most significant risk factors were related to habitat, socio‐economic factors and wild boar management. The effectiveness of different control options in the so‐named white zones, areas where wild boar densities have been drastically reduced to avoid further spread of ASF after a new introduction, was assessed with a stochastic model. Important findings were that establishing a white zone is much more challenging when the area of ASF incursion is adjacent to an area where limited control measures are in place. Very stringent wild boar population reduction measures in the white zone are key to success. The white zone needs to be far enough away from the affected core area so that the population can be reduced in time before the disease arrives and the timing of this will depend on the wild boar density and the required population reduction target in the white zone. Finally, establishing a proactive white zone along the demarcation line of an affected area requires higher culling efforts, but has a higher chance of success to stop the spread of the disease than establishing reactive white zones after the disease has already entered in the area.

The Foreign Policy of the European Union: Assessing Europe's Role in the World

Abstract: In a relatively short time, the EU has become one of the most important actors on the world stage. This updated second edition of The Foreign Policy of the European Union explores the goals and effectiveness of the EU's external actions after adoption of the Lisbon Treaty. The book brings together prominent scholars and policymakers who provide an up-to-date view of the EU's foreign policy merits and challenges. ""The role and place of the European Union in the world has been a constant question for all of the actors involved...This book reminds us well of the importance of this question and offers a particularly welcome general overview during these times of doubt and pessimism."" --Pierre Vimont, from the foreword

Sustainable development in the European Union

Abstract: For many, the definition of sustainable development provided in the Brundtland Report marked the beginning of the era of sustainability. This chapter that there remains much rhetoric, not action, in the sustainability debate in the European Union (EU), undermining the credibility of the brand and the opportunity for sustainability to become ‘the vision’ for the future of the EU. Notions of sustainability transition are prominent in academic literature and influence EU policy frameworks. The Sustainable Development Goals will be at the heart of EU’s policymaking and action. The EU and the Member States share the competence for action on sustainability. The EU is proposing strategies, including measures to be put into operation at the national and sub-national levels. The objective of sustainability has been mainstreamed into EU domestic and external policies. Within the EU, the increased commitment to sustainability resulted in a deepening of the process of European integration from the late 1980s.

Comparing Public Policies: Issues and Choices in Industrialized Countries

Abstract: The study of comparative public policy reveals the intensely political nature of policy choices. While policy analysts often look to policy successes and failures outside their borders to draw valuable lessons and insights, cultural, economic, political, and institutional conditions vary from country to country and strongly affect how policy analysis is ultimately used. By combining a conceptual discussion of policy making with an examination of seven specific policy areas, Jessica Adolino and Charles Blake show how politics-in the realm of the environment, education, taxation, economics, immigration, health care, and social welfare-shapes policy choices. The second edition of Comparing Public Policies has been revised and updated to reflect the most recent political and policy developments. This new edition expands coverage of the internationalization of domestic policy making by including a European Union case study in each issue area, along with further discussion of the role of international interest groups in the policy process. The seven policy chapters have been revised and updated to examine current issues in the United States, Japan, Germany, France, the United Kingdom, Italy, and the European Union, such as: - the heightened calls for immigration policy reform - the return to higher budget deficits in several countries - the efforts to lower tax rates in countries with falling expenditures and in countries with rising spending levels - the often unsuccessful attempts to control increasing health care costs in countries with aging populations - the spirited debate over the future role of the welfare state in an increasingly globalized economy - the, at times, divergent education reform debates regarding the role of assessment and calls for decentralization - the uneven environmental performance in the reduction of carbon dioxide emissions Chapters include analyses of crossnational trends-past and present-and a final chapter reexamines the internationalization of public policy in industrialized countries. Useful pedagogical features have been incorporated throughout the text, including "In Depth" boxes that offer detailed discussion of the political process or analytical techniques, and "Country At-a-Glance" boxes that provide quick reference to political institutions. A wealth of recent data is displayed in numerous tables and a glossary gives students a practical guide to terminology.

Review and outlook on the international renewable energy development

Abstract: Renewable energy has become an important choice to solve the energy crisis and environmental problems. A sustainable development needs policies and strategies policies, which can improve energy efficiency and reduce greenhouse gas emissions. By collecting the research results released by relevant statistical departments and authoritative institutions, this paper summarizes the international energy development situation, systematically combs the energy development situation of the European Union, United States, Australia, India, Brazil. The development trend of wind, solar, biomass, geothermal, ocean, and hydrogen energy have been analyzed. In addition, this paper proposes that China should draw up its own development path of renewable energy from international development experience, and actively explore renewable energy policies and strategies adapted to different stages of development.

Osteoporosis in Europe: a compendium of country-specific reports

Abstract: Abstract Summary This report describes epidemiology, burden, and treatment of osteoporosis in each of the 27 countries of the European Union plus Switzerland and the UK (EU 27+2). Introduction The aim of this report was to characterize the burden of osteoporosis in each of the countries of the European Union plus Switzerland and the UK in 2019 and beyond. Methods The data on fracture incidence and costs of fractures in the EU27+2 was taken from a concurrent publication in this journal (SCOPE 2021: a new scorecard for osteoporosis in Europe) and country-specific information extracted. The information extracted covered four domains: burden of osteoporosis and fractures; policy framework; service provision; and service uptake. Results The clinical and economic burden of osteoporotic fractures in 2019 is given for each of the 27 countries of the EU plus Switzerland and the UK. Each domain was ranked and the country performance set against the scorecard for all nations studied. Data were also compared with the first SCOPE undertaken in 2010. Fifteen of the 16 score card metrics on healthcare provision were used in the two surveys. Scores had improved or markedly improved in 15 countries, remained constant in 8 countries and worsened in 3 countries. The average treatment gap increased from 55% in 2010 to 71% in 2019. Overall, 10.6 million women who were eligible for treatment were untreated in 2010. In 2019, this number had risen to 14.0 million. Conclusions In spite of the high cost of osteoporosis, a substantial treatment gap and projected increase of the economic burden driven by aging populations, the use of pharmacological prevention of osteoporosis has decreased in recent years, suggesting that a change in healthcare policy concerning the disease is warranted.

Tinnitus prevalence in Europe: a multi-country cross-sectional population study

Abstract: Tinnitus prevalence studies report large variability across countries that might be due to inconsistent research methods. Our study aimed to report a single Pan-European estimate for tinnitus prevalence and investigate the effect of individual and country-level characteristics on prevalence. We explored the relationships of healthcare resource use and hearing difficulty with tinnitus symptoms.Between 2017-2018, a cross-sectional European Tinnitus Survey (ETS) was conducted in 12 European Union nations (Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania, and Spain), using a standardised set of tinnitus-related questions and response options in country-specific languages. We recruited 11,427 adults aged ≥18 years.Prevalence of any tinnitus was 14·7% (14·0% in men and 15·2% in women), ranging from 8·7% in Ireland to 28·3% in Bulgaria. Severe tinnitus was found in 1·2% participants (1·0% in men and 1·4% in women), ranging from 0·6% in Ireland to 4·2% in Romania. Tinnitus prevalence significantly increased with increasing age and worsening of hearing status. Healthcare resource use for tinnitus increased with increasing tinnitus symptom severity.This is the first multinational report of Pan-European tinnitus prevalence using standardised questions. The overall prevalence estimates refine previous findings, although widespread inter-country heterogeneity was noted. The results indicate that more than 1 in 7 adults in the EU have tinnitus. Extrapolating to the overall population, approximately 65 million adults in EU28 have tinnitus, 26 million have bothersome tinnitus and 4 million have severe tinnitus.National Institute for Health Research, European Union's Horizon 2020, Medical Research Council, and GENDER-Net Co-Plus Fund.

Algae as Food in Europe: An Overview of Species Diversity and Their Application

Abstract: Algae have been consumed for millennia in several parts of the world as food, food supplements, and additives, due to their unique organoleptic properties and nutritional and health benefits. Algae are sustainable sources of proteins, minerals, and fiber, with well-balanced essential amino acids, pigments, and fatty acids, among other relevant metabolites for human nutrition. This review covers the historical consumption of algae in Europe, developments in the current European market, challenges when introducing new species to the market, bottlenecks in production technology, consumer acceptance, and legislation. The current algae species that are consumed and commercialized in Europe were investigated, according to their status under the European Union (EU) Novel Food legislation, along with the market perspectives in terms of the current research and development initiatives, while evaluating the interest and potential in the European market. The regular consumption of more than 150 algae species was identified, of which only 20% are approved under the EU Novel Food legislation, which demonstrates that the current legislation is not broad enough and requires an urgent update. Finally, the potential of the European algae market growth was indicated by the analysis of the trends in research, technological advances, and market initiatives to promote algae commercialization and consumption.

A comprehensive review of green policy, anaerobic digestion of animal manure and chicken litter feedstock potential – Global and Irish perspective

Abstract: Renewable energy has become increasingly popular in the recent times as countries have shifted focus towards carbon-neutral and environmentally sustainable sources of energy. Biogas and biomethane derived energy from Anaerobic Digestion of organic waste have proved to be excellent alternative to fossil-fuel based energy. Many countries around the world are actively adopting biomethane as an alternative to petrol/diesel or use biogas to provide energy for the domestic sector through combined heat and power plants. The contribution of anaerobic digestion in the Irish energy sector remains quite low as compared to its European union counterparts due to related legislation and lack of government incentives. Nevertheless, Ireland is rich in biomass with a huge potential for developing its renewable energy sector from anaerobic digestion of agricultural waste, which is relatively inexpensive and available here in abundance. Chicken litter is one such waste which offers a variety of environmental benefits as anaerobic digestion feedstock. In comparison to cow manure and pig manure, chicken litter was relatively unpopular in anaerobic digestion due to its high nitrogen and lignocellulose content. Further, the global production of chicken manure has been increasing constantly thus making its disposal challenging across the world. However, researchers have identified many optimisation strategies to overcome these issues and demonstrated the advantages of using chicken litter in anaerobic digestion including odor reduction, greenhouse gas mitigation, production of gaseous biofuel, avoiding eutrophication of water bodies and significantly improving global production of renewable energy to help countries reduce their carbon emissions.

Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States

Abstract: Introduction This study aims to provide a risk assessment of the adverse reactions related to the COVID-19 vaccines manufactured by AstraZeneca, Janssen, Moderna, and Pfizer-BioNTech which have been in use in the European Union and the United States between December 2020 and October 2021. Methods Data from the European Database of Suspected Adverse Drug Reaction (EudraVigilance) and the Vaccine Adverse Events Reporting System (VAERS) from 2020 to October 2021 are analysed. More than 7.8 million adverse reactions of about 1.6 million persons are included. The adverse reactions are classified with the Common Toxicity Criteria (CTC) categories. COVID-19 vaccine exposures and adverse reactions reported between December 2020 and October 2021 are compared to influenza vaccine exposures and adverse reactions reported between 2020 and 2021. The population-level vaccine exposures to COVID-19 and influenza vaccines comprised about 451 million and 437 million exposures, respectively. Absolute and relative risk estimates are calculated by CTC categories and COVID-19 vaccines for the EU and US populations aged 18 years and older. Results A higher risk of reporting serious adverse reactions was observed for the COVID-19 vaccines in comparison to the influenza vaccines. Individuals age 65 and older were associated with a higher frequency of death, hospitalisations, and life-threatening reactions than younger individuals (relative risk estimates between 1.49 99% CI [1.44–1.55] and 8.61 99% CI [8.02–9.23]). Outcome onset of serious adverse reactions occurred within the first 7 days after vaccination in about 77.6–89.1% of cases. The largest absolute risks were observed for allergic, constitutional reactions, dermatological, gastrointestinal, neurological reactions, and localised and non-localised pain. The largest relative risks between COVID-19 vs. influenza vaccines were observed for allergic reactions, arrhythmia, general cardiovascular events, coagulation, haemorrhages, gastrointestinal, ocular, sexual organs reactions, and thrombosis. Conclusion The present study provides an overview of adverse reactions frequently reported to the pharmacovigilance systems following COVID-19 vaccination in the EU and US populations. Despite the limitations of passive reporting systems, these results may inform further clinical research investigating in more detail the pathophysiological mechanisms potentially associated with the COVID-19 vaccines.